Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Alice F. Ellison"'
Autor:
Thomas O. Carpenter, Caren M. Gundberg, Jane E. Kerstetter, Alice F. Ellison, Maryann Mitnick, Karl L. Insogna, Donna M. Caseria
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 84:1052-1055
Although high protein diets are known to increase urinary calcium excretion and induce negative calcium balance, the impact of dietary protein on bone turnover and fractures is controversial. We therefore evaluated the effect of dietary protein on ma
Autor:
Florence Comite, Alice F. Ellison, Cynthia Smith, A R Poole, R Travers, Caren M. Gundberg, Dana S. Schwartz, Marc S. Keller, Karl L. Insogna, F H Glorieux, Maryann Mitnick, Ronald L. Horst, Thomas O. Carpenter, D Carey
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 81:2381-2388
Therapy for X-linked hypophosphatemia (XLH) only partially corrects skeletal lesions and is often complicated by hyperparathyroidism. 24,25(OH)2 D3 improves skeletal lesions in a murine model of XLH and suppresses PTH secretion in animals. Therefore,
Publikováno v:
Archives of Dermatology. 135
Background Few studies have been done of bone densities in humans receiving retinoids, despite a substantial amount of literature concerning retinoid-induced osteoporosis in animals. We prospectively measured bone density and calcium metabolism in yo
Publikováno v:
The Journal of clinical endocrinology and metabolism. 78(6)
Parathyroid function is described as normal in patients with phosphopenic rickets before initiation of therapy with phosphate salts; however, hyperparathyroidism is an occasional complication of treatment. We observed a higher than expected frequency
Publikováno v:
Archives of Dermatology. 128:926
• Background and Design.— After the chance observation of an elevated parathyroid hormone (PTH) value in a patient with pityriasis rubra pilaris, the serum PTH level was measured in the next 14 patients seen with disorders of keratinization. Calc
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 66:72-75
We determined the metabolic clearance and production rates of 1,25-dihydroxyvitamin D [1,25-(OH)2D] in 5 patients with sarcoidosis who had either hypercalciuria or hypercalcemia to examine whether abnormalities in the metabolism of this hormone exist
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 61:490-495
Previous studies of 1,25-dihydroxyvitamin D [1,25-(OH)2D] kinetics in normal subjects using the pulse injection technique have led to conflicting results, and only limited data are available concerning 1,25-(OH)2D kinetics in hypercalciuric patients.
Publikováno v:
The New England journal of medicine. 311(2)
In previous studies, we observed increases in the circulating concentration and production rate of 1,25-dihydroxyvitamin D (1,25-(OH)2D) in a large majority of patients with the syndrome of absorptive hypercalciuria. In the present study, the hypothe
Autor:
Alan S. Kliger, Alice F. Ellison, Robert Lang, Joseph M. Gertner, Lawrence E. Mallette, A E Broadus, Karl L. Insogna, Dan A. Orenlang
Publikováno v:
The Journal of clinical endocrinology and metabolism. 58(1)
Fifty patients with absorptive hypercalciuria (AH), 25 normal subjects (NS), and 25 nonhypercalciuric patients with stone disease (NHSF) were studied using an oral calcium tolerance test and 24-h urine collections on both a restricted and an unrestri